Description
Trihale Rotacap 200 mcg is a combination inhalation capsule manufactured by ACME Laboratories Ltd., designed for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Each capsule contains a blend of three active ingredients:
-
Umeclidinium Bromide (62.5 mcg): A long-acting muscarinic antagonist (LAMA) that helps to relax the muscles around the airways in the lungs, leading to bronchodilation.
-
Vilanterol Trifenatate (25 mcg): A long-acting beta-agonist (LABA) that stimulates beta receptors in the lungs, resulting in bronchodilation and improved airflow.
-
Fluticasone Furoate (200 mcg): A corticosteroid that reduces inflammation in the airways, helping to prevent exacerbations and improve breathing.
These components work synergistically to provide comprehensive management of COPD symptoms, improving lung function and quality of life for patients.
.jpeg)
.jpeg)
.png)
.png)
.jpeg)
.webp)
.png)
.webp)
.webp)
Change Language